A detailed history of Quent Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Quent Capital, LLC holds 469 shares of BDX stock, worth $106,781. This represents 0.01% of its overall portfolio holdings.

Number of Shares
469
Previous 589 20.37%
Holding current value
$106,781
Previous $137,000 17.52%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$221.47 - $242.41 $26,576 - $29,089
-120 Reduced 20.37%
469 $113,000
Q2 2024

Jul 08, 2024

SELL
$225.07 - $246.17 $19,356 - $21,170
-86 Reduced 12.74%
589 $137,000
Q1 2024

May 02, 2024

SELL
$233.45 - $247.73 $6,069 - $6,440
-26 Reduced 3.71%
675 $167,000
Q4 2023

Jun 14, 2024

SELL
$232.24 - $267.23 $232 - $267
-1 Reduced 0.14%
701 $170,000
Q4 2023

Jan 19, 2024

SELL
$232.24 - $267.23 $232 - $267
-1 Reduced 0.14%
701 $170,000
Q3 2023

Jun 14, 2024

BUY
$254.9 - $283.59 $509 - $567
2 Added 0.29%
702 $181,000
Q3 2023

Oct 10, 2023

BUY
$254.9 - $283.59 $509 - $567
2 Added 0.29%
702 $181,000
Q1 2023

Jun 14, 2024

BUY
$229.71 - $259.35 $5,742 - $6,483
25 Added 3.7%
700 $173,000
Q1 2023

Apr 05, 2023

BUY
$229.71 - $259.35 $8,499 - $9,595
37 Added 5.58%
700 $173,000
Q4 2022

Jan 19, 2023

BUY
$218.29 - $256.91 $2,182 - $2,569
10 Added 1.53%
663 $0
Q2 2022

Aug 08, 2022

SELL
$234.74 - $275.42 $4,929 - $5,783
-21 Reduced 3.12%
653 $161,000
Q1 2022

May 12, 2022

BUY
$243.64 - $270.48 $66,757 - $74,111
274 Added 68.5%
674 $179,000
Q4 2021

Feb 28, 2022

BUY
$230.08 - $250.94 $92,032 - $100,376
400 New
400 $101,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.